OFFRE LISEUSES
Une liseuse achetée = une housse offerte* jusqu'au 21 juin
Unlocking Cancer's Hidden Targets
Par :Formats :
Disponible dans votre compte client Decitre ou Furet du Nord dès validation de votre commande. Le format ePub est :
- Compatible avec une lecture sur My Vivlio (smartphone, tablette, ordinateur)
- Compatible avec une lecture sur liseuses Vivlio
- Pour les liseuses autres que Vivlio, vous devez utiliser le logiciel Adobe Digital Edition. Non compatible avec la lecture sur les liseuses Kindle, Remarkable et Sony
, qui est-ce ?Notre partenaire de plateforme de lecture numérique où vous retrouverez l'ensemble de vos ebooks gratuitement
Pour en savoir plus sur nos ebooks, consultez notre aide en ligne ici
C'est si simple ! Lisez votre ebook avec l'app Vivlio sur votre tablette, mobile ou ordinateur :
- FormatePub
- ISBN8995580805
- EAN9798995580805
- Date de parution13/04/2026
- Protection num.pas de protection
- Infos supplémentairesepub
- ÉditeurMASONCORP LLC
Résumé
Unlocking Cancer's Hidden Targets: The Revolutionary Science of Cancer-Testis Antigens in Modern Immunotherapy is a comprehensive scientific guide that explores the groundbreaking intersection of cancer-testis antigen research and modern immunotherapy. Written by Dr. Maurizio Chiriva Internati, a pioneering researcher with over two decades of experience in immuno-oncology, this book provides an in-depth examination of how cancer-testis antigens are transforming the landscape of personalized cancer treatment.
From the foundational discovery of sperm protein 17 as a novel cancer-testis antigen to the development of AI-driven platforms for personalized target discovery, this work covers the full spectrum of translational research in cancer immunotherapy. Readers will explore the molecular mechanisms underlying cancer-testis antigen expression, the clinical applications of cancer vaccines across multiple tumor types, and the revolutionary manufacturing processes that are making personalized immunotherapy a clinical reality.
This book bridges the gap between laboratory science and clinical application, offering oncologists, immunologists, biotech professionals, medical students, and researchers a thorough understanding of the current state and future directions of cancer-testis antigen-based immunotherapy. With over 215 scientific references and detailed analysis of FDA regulatory pathways, vaccine development strategies, and emerging technologies including mRNA-based cancer vaccines, this work serves as both an authoritative reference and an accessible guide to one of the most promising frontiers in modern oncology.
From the foundational discovery of sperm protein 17 as a novel cancer-testis antigen to the development of AI-driven platforms for personalized target discovery, this work covers the full spectrum of translational research in cancer immunotherapy. Readers will explore the molecular mechanisms underlying cancer-testis antigen expression, the clinical applications of cancer vaccines across multiple tumor types, and the revolutionary manufacturing processes that are making personalized immunotherapy a clinical reality.
This book bridges the gap between laboratory science and clinical application, offering oncologists, immunologists, biotech professionals, medical students, and researchers a thorough understanding of the current state and future directions of cancer-testis antigen-based immunotherapy. With over 215 scientific references and detailed analysis of FDA regulatory pathways, vaccine development strategies, and emerging technologies including mRNA-based cancer vaccines, this work serves as both an authoritative reference and an accessible guide to one of the most promising frontiers in modern oncology.